Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer

TMPRSS2-ERG fusion prostate cancer is a distinct molecular subclass. TMPRSS2-ERG expression is regulated by a novel ER-dependent mechanism.